UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA
Clinical trials for UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cancer immunotherapy drug shrink rare sarcomas?
Disease control OngoingThis phase 2 trial tests the drug atezolizumab in 27 people with chondrosarcoma or clear cell sarcoma that cannot be removed by surgery or has spread. Atezolizumab is an immunotherapy that helps the body's immune system attack cancer cells. The main goal is to see if the drug can…
Matched conditions: UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug cocktail targets rare bone cancer that spreads
Disease control OngoingThis study tests two drug combinations (belinostat plus either guadecitabine or ASTX727) in 19 adults with a rare bone cancer called chondrosarcoma that has spread or cannot be removed surgically. The goal is to see if the drugs can shrink tumors or stop them from growing. Partic…
Matched conditions: UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for rare bone cancer? drug shows promise in early trial
Disease control OngoingThis phase 2 trial tested vismodegib, a pill that targets a specific growth pathway, in 45 people with advanced chondrosarcoma (a rare bone cancer). The goal was to see if the drug could shrink tumors or stop them from growing. Participants had to have measurable disease and no m…
Matched conditions: UNRESECTABLE PRIMARY CENTRAL CHONDROSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC